Hansa Biopharma AB (publ)

BATS-CHIXE:HNSAS Stock Report

Market Cap: SEK 1.7b

Hansa Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: HNSAS insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HNSAS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies644,8001.23%
Individual Insiders2,849,4915.43%
Hedge Funds10,626,13120.3%
Institutions13,881,22126.5%
General Public24,442,31946.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 57.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.3%
Redmile Group, LLC
10,626,131SEK 348.5m0%1.08%
4.21%
Fourth Swedish National Pension Fund (AP4)
2,207,397SEK 72.4m0%0.03%
4.11%
Nexttobe AB
2,155,379SEK 70.7m0%23.75%
3.76%
Invesco Ltd.
1,973,931SEK 64.7m0%no data
3.66%
Thomas Olausson
1,917,000SEK 62.9m0%no data
2.65%
Tredje AP-fonden
1,389,650SEK 45.6m0%0.02%
2.33%
The Vanguard Group, Inc.
1,223,839SEK 40.1m0%no data
2.02%
Avanza Fonder AB
1,057,312SEK 34.7m-40.1%0.1%
1.86%
Braidwell LP
974,528SEK 32.0m0%0.16%
1.69%
Schroder Investment Management Limited
888,132SEK 29.1m0%no data
1.68%
Handelsbanken Asset Management
879,183SEK 28.8m0%no data
1.64%
Theodor Jeansson
860,000SEK 28.2m0%no data
1.52%
C WorldWide Asset Management Fondsmaeglerselskab A/S
799,749SEK 26.2m0%0.02%
1.27%
Heights Capital Management, Inc.
667,169SEK 21.9m0%0.98%
1.23%
Vob & T Trading AB
644,800SEK 21.1m0%no data
0.98%
Norges Bank Investment Management
515,571SEK 16.9m0%no data
0.64%
SEB Investment Management AB
335,579SEK 11.0m0%no data
0.34%
Assenagon Asset Management S.A.
180,714SEK 5.9m0%no data
0.31%
Storebrand Fonder AB,
164,340SEK 5.4m0%no data
0.29%
Aramea Asset Management AG
150,000SEK 4.9m20%0.08%
0.28%
State Street Global Advisors, Inc.
148,333SEK 4.9m1.38%no data
0.25%
Skandia Fonder AB
130,417SEK 4.3m0%no data
0.24%
FCG Fonder AB
127,186SEK 4.2m0%0.14%
0.1%
Tcax Förvaltning Ab
52,746SEK 1.7m0%no data
0.088%
Financiere Arbevel
46,000SEK 1.5m0%0.03%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/01/10 21:09
End of Day Share Price 2023/10/13 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hansa Biopharma AB (publ) is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Christian LeeABG Sundal Collier Sponsored
Madhu KumarB. Riley Securities, Inc.